DUBLIN--(BUSINESS WIRE)--The "8th Annual Biologics World Taiwan 2020" conference has been added to ResearchAndMarkets.com's offering.

While China, India, and Korea are leading the pack in the Asian region for biologics, Taiwan has also been stepping up its efforts to boost its biologics sector and capture a share of the global market. In 2009, the Taiwan Biotechnology Takeoff Diamond Action Plan was launched by the government, with the aim of strengthening the country's translational research and commercialisation skills, establishing a biotechnology venture capital fund, founding a Food and Drug Administration, and creating an integrated biotech incubation center.

Two biotechnology clusters have already been built in Taiwan, with the Southern Taiwan Science Park hosting nearly 20 biopharmaceutical companies, and the Hsinchu Biomedical Science Park expected to accommodate 30 biopharmaceutical manufacturers. The government also plans to create an integrated incubation center, to be developed in a third park and called the National Biotechnology Development Park, which will also contain animal testing, R&D service, and legal information centers.

Biologics World Taiwan provides the FIRST and ONLY platform for senior decision-makers who will influence the future of Taiwan's biologics industry. Taiwanese and international biopharmas, biotechs, CMOs, CROs, and solution providers will convene to discuss strategic issues, leverage partnerships, share best practices, and capitalize on the potential of Taiwan's growing biologics industry.

Sources / Contributors

• Shue-Yuen Wang, Consultant, Development Center for Biotechnology, Taiwan
• Jason Huang, Chief Medical Officer, BRIM Biotech, Taiwan
• Shuichi Yamamoto, Director, Biomedical Engineering Center (YUBEC) & Professor Bio-Process Engineering Laboratory, Yamaguchi University, Japan
• Ko-Chung Lin, CEO & Founder, PharmaEssentia, Taiwan
• Juine-Ruey Chen, Vaccine R&D Director, RH Biopharma, Taiwan
• Mahalia Corrales, Senior Director of Process Development, JHL Biotech, Taiwan
• Lee Cheng Liu, President & CEO, Eirgenix, Taiwan
• Pauline Y. Lau, CEO, Suntec Medical, Taiwan
• Julio Lin, Vice President, Blue Blood Biotech Corp, Taiwan
• Dr. Leah Lo, CEO, Orient Pharma, Taiwan
• Dr. Ye-Su Chao, Vice President, GNTbm, Taiwan
• Dr. Allen Chao, CEO, Tanvex, Taiwan
• Alvan Chou, R&D Director, Mycenax Biotech, Taiwan
• Yuan-Hua Ding, Vice President and Head, Asia Discovery Labs Emerging Science & Innovation (ES&I), Pfizer Worldwide Research, Development and Medical, China
• John (Tsu-An) Hsu, Investigator, Division Biotechnology and Pharmaceutical Research, National Health Research Institutes, Taiwan
• Dr. Frieda Chou, Director - Quality Management, United Biopharma, Taiwan
• Tzu Hung Lin, Research Scientist, Industrial Technology Research Institute (ITRI), Taiwan
• Wan-Jiun Chen, Deputy Director, Cancer Stem Cells Therapeutics Department, Oneness Biotech, Taiwan
• Hsiu-Ling Hsiao, Chief Scientific Officer, Ever Supreme, Taiwan
• Eric Thang, Chairman/CEO, Lukas Biomedical Inc, Taiwan
• Shih-Hwa Chiou, Professor, National Yang-Ming University, Taiwan
• Stanley Chang, CEO/Chairman, Medigen Biotechnology Corp, Taiwan
• Rita Yen-Hua Huang, CEO/Director, TMU Research Center for Cell Therapy & Regeneration Medicine, Taiwan
• Chun-Che Yen, Deputy General Manager, Kartigen Biomedical Taiwan
• Wan-Jiun Chen, Deputy Director, Cancer Stem Cells Therapeutics Department, Oneness Biotech Taiwan
• Dar-Jen Hsieh, CEO, ACRO Biomedical Co. Ltd, Taiwan
• Prof Liu Hua Chang, Professor Emeritus of Orthopaedic Surgery, National Taiwan University, Taiwan
• Dr Po Cheng Lin, General Manager, GWOXI, Taiwan
• Hun-Chi Lin, CEO, Li Bo Pharma Corp, Taiwan
• Jan Mou Lee, Founder, Fullhope Biomedical, Taiwan
• Dr William Hung, Physician, Maria Von, Taiwan
• Yi Pei Hung, General Manager, Yupro Biomedical Services, Taiwan

For more information about this conference visit https://www.researchandmarkets.com/r/2umceg

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900